DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Park KS, Kwak S, Cho YM. et al.
Vildagliptin reduces plasma stromal cell-derived factor-1α in patients with type 2 diabetes compared with glimepiride.
J Diabetes Investig 2017;
8: 218-826
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.